Health and Fitness Health and Fitness
Tue, October 19, 2010
[ Tue, Oct 19th 2010 ] - Market Wire
Aetna Agreement with The Chester County Hospital Features Incentives for Quality Initiatives
[ Tue, Oct 19th 2010 ] - Market Wire
Psychiatric Solutions Announces Third Quarter 201 .. ed Share on 10.4% Growth in Same-Facility Revenue
[ Tue, Oct 19th 2010 ] - Market Wire
Capsalus Corp. Announces Ticker Symbol Change to aWELLa
[ Tue, Oct 19th 2010 ] - Market Wire
Orthofix International Announces Promotion of Jef .. humm To Senior Vice President and General Counsel
[ Tue, Oct 19th 2010 ] - Market Wire
MannKind Announces Initiation of Phase 2 Trial of Cancer Vaccine for Advanced Melanoma
[ Tue, Oct 19th 2010 ] - Market Wire
USANA Schedules Third Quarter Earnings Release and Conference Call
[ Tue, Oct 19th 2010 ] - Market Wire
Vitro Expands HemoGenix Alliance to Include Cell-based Testing for Liver Toxicity
[ Tue, Oct 19th 2010 ] - Market Wire
Fonds de solidarite FTQ Converting Remainder of its Preferred Shares in Bioniche
[ Tue, Oct 19th 2010 ] - Market Wire
Greatbatch, Inc. to Host Third Quarter 2010 Earnings Conference Call on Thursday, October 28, 2010
[ Tue, Oct 19th 2010 ] - Market Wire
Seattle Genetics to Host Conference Call and Webc .. uarter 2010 Financial Results on November 1, 2010
[ Tue, Oct 19th 2010 ] - Market Wire
AtriCure to Announce Third Quarter 2010 Financial Results
[ Tue, Oct 19th 2010 ] - Market Wire
MabCure Signs a Collaboration Agreement with a Le .. e for a Study Aimed at Further Development of a B
[ Tue, Oct 19th 2010 ] - Market Wire
Deciso da corte distrital recebida no processo da patente NPWT
[ Tue, Oct 19th 2010 ] - Market Wire
Micromet to Report Third Quarter 2010 Financial Results on November 9
[ Tue, Oct 19th 2010 ] - Market Wire
Tribunal de distrito emiti decisin en litigio por patentes de NPWT
[ Tue, Oct 19th 2010 ] - Market Wire
Gerichtsentscheidung im NPWT-Patentverfahren durch District Court
[ Tue, Oct 19th 2010 ] - Market Wire
Besluit arrondissementsrechtbank ontvangen in octrooizaak NPWT
[ Tue, Oct 19th 2010 ] - Market Wire
Forest Laboratories, Inc. Reports Second Quarter Fiscal Year 2011 Earnings Per Share of $1.00
[ Tue, Oct 19th 2010 ] - Market Wire
Aeterna Zentaris CEO to Chair Cancer Symposium Se .. Annual Congress of International Drug Discovery S
[ Tue, Oct 19th 2010 ] - Market Wire
Flamel Technologies Achieves Clinical Milestone w .. xtended Release Formulation of Interferon beta-1a
[ Tue, Oct 19th 2010 ] - Market Wire
Compugen Ltd. to Review Third Quarter 2010 Financial Results on Tuesday, October 26, 2010
Mon, October 18, 2010
[ Mon, Oct 18th 2010 ] - Market Wire
ShangPharma Corporation Announces Pricing of Init .. Public Offering of its American Depositary Shares
[ Mon, Oct 18th 2010 ] - Market Wire
Law Offices of Howard G. Smith Announces Investig .. rs of AGA Medical Holdings, Inc. in Connection wi
[ Mon, Oct 18th 2010 ] - Market Wire
Finkelstein Thompson LLP Announces Investigation of AGA Medical Holdings, Inc.
[ Mon, Oct 18th 2010 ] - Market Wire
Finkelstein Thompson LLP Announces Investigation of China-Biotics, Inc.
[ Mon, Oct 18th 2010 ] - Market Wire
Cubist Announces Offering of Convertible Senior Notes
[ Mon, Oct 18th 2010 ] - Market Wire
Idera Pharmaceuticals to Present at the 17th Annual NewsMakers in the Biotech Industry Conference
[ Mon, Oct 18th 2010 ] - Market Wire
Emeritus Announces Lease Signing for 27 Senior Living Communities
[ Mon, Oct 18th 2010 ] - Market Wire
Columbia Laboratories to Present at the NewsMaker .. e Biotech Industry Conference on October 22, 2010
[ Mon, Oct 18th 2010 ] - Market Wire
SuperGen to Announce 2010 Third Quarter Financial Results on October 25, 2010

SuperGen to Announce 2010 Third Quarter Financial Results on October 25, 2010


Published on 2010-10-18 13:15:14 - Market Wire
  Print publication without navigation


DUBLIN, Calif.--([ BUSINESS WIRE ])--SuperGen, Inc. (Nasdaq:SUPG), a pharmaceutical company dedicated to discovery and development of novel cancer therapies, announced that it will release its 2010 third quarter financial results on Monday, October 25, 2010. SuperGen's management team will provide details of the Company's financial results and any revised outlook for the future.

A press release will be issued following the close of the market on October 25th. The Company will host a webcast conference call to discuss the results at 4:30 p.m. ET. A live webcast of the call will be available in the Investor Events section of the Company's Web site at [ www.supergen.com ]. A webcast replay of the live conference call will be available shortly following the event. Alternatively, you may access a replay of the conference call by dialing 800-642-1687 (domestic) and 706-645-9291 (international); replay passcode number is 18969641. The webcast replay and conference call replay will be available for 30 days.

About SuperGen

SuperGen is a pharmaceutical company dedicated to discovery and development of novel cancer therapeutics in epigenetic and cell signaling modulation. The Company develops products through biochemical and clinical proof of concept to partner for further development and commercialization. For more information about SuperGen, please visit [ http://www.supergen.com ].

Contributing Sources